Although some smaller studies did not reach statistical significance due to wide confidence intervals (e.g., Huang Z 2012: OR = 13.95, 95% CI [0.75, 259.34]) ( 23 ), the overall consistent direction of effect across all studies strongly suggests that dexmedetomidine use is associated with elevated bradycardia risk.
← all excerpts
Safety and adverse events associated with dexmedetomidine for sedation in adult ICU patients: a systematic review and meta-analysis.
1
—
—